Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
BMC Pulmonary Medicine|August 2, 2025
Peripheral and pulmonary telomere lengths in patients with non-idiopathic pulmonary fibrosis interstitial lung diseasesYujie Shi, Yanyan Li, Ruxuan Chen, et al.
BMC Cancer|September 7, 2016
Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patientsLi Min, Cheng Zhang, Ruolan Ma, et al.
Respiratory Research|May 14, 2026
Nerandomilast attenuates Pantoea agglomerans-induced hypersensitivity pneumonitis by regulating M1 macrophage polarization and fibroblast activationYujie Shi, Yuming Liu, Zhigang Liu, et al.
BMC Pulmonary Medicine|April 29, 2025
Clinical analysis of patients with idiopathic pulmonary fibrosis concurrent with surgery resectable lung cancer: a retrospective cohort study from perspective of ILD physiciansQi Chen, Yujie Shi, Ruxuan Chen, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2024
Bronchoalveolar lavage fluid analysis in patients with checkpoint inhibitor pneumonitisRuxuan Chen, Yujie Shi, Nan Fang, et al.
Clinical and Experimental Medicine|January 30, 2023
Clinical spectrum of Chinese hospitalized lung cancer patients with concomitant interstitial lung disease: before and after the new era of LC treatmentRuxuan Chen, Chi Shao, Xiangning Liu, et al.
Hematology (Amsterdam, Netherlands)|October 3, 2025
Clinical analysis of eight patients with lung biopsy-proven pulmonary intravascular large B-cell lymphoma in a single centerYujie Shi, Kai Xu, Ji Li, et al.
International Immunopharmacology|December 3, 2022
Tacrolimus ameliorates bleomycin-induced pulmonary fibrosis by inhibiting M2 macrophage polarization via JAK2/STAT3 signalingBowen Liu, Qiuyan Jiang, Ruxuan Chen, et al.
Critical Reviews in Food Science and Nutrition|October 4, 2025
Mechanisms of flavonoid-mediated amelioration of MASLD: flavonoids, their metabolites or impact on gut microbes?Ruxuan Chen, Xionghui Wu, Ning Yin, et al.
International Immunopharmacology|June 4, 2025
Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathwayZhongyi Yang, Zhiyi Li, Zhigang Liu, et al.
Pageof 5